19-51693200-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000602324.1(SPACA6-AS1):​n.257A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 556,212 control chromosomes in the GnomAD database, including 52,308 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 17371 hom., cov: 30)
Exomes 𝑓: 0.38 ( 34937 hom. )

Consequence

SPACA6-AS1
ENST00000602324.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.575

Publications

64 publications found
Variant links:
Genes affected
SPACA6-AS1 (HGNC:49383): (SPACA6 antisense RNA 1)
SPACA6 (HGNC:27113): (sperm acrosome associated 6) Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to be located in acrosomal vesicle. [provided by Alliance of Genome Resources, Apr 2022]
MIR125A (HGNC:31505): (microRNA 125a) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.87 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPACA6NM_001316972.2 linkc.-327T>C upstream_gene_variant ENST00000637797.2 NP_001303901.1 W5XKT8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPACA6ENST00000637797.2 linkc.-327T>C upstream_gene_variant 1 NM_001316972.2 ENSP00000490829.1 W5XKT8-1

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67675
AN:
151642
Hom.:
17333
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.305
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.892
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.399
Gnomad MID
AF:
0.253
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.400
GnomAD4 exome
AF:
0.384
AC:
155324
AN:
404452
Hom.:
34937
Cov.:
0
AF XY:
0.383
AC XY:
83000
AN XY:
216458
show subpopulations
African (AFR)
AF:
0.663
AC:
7723
AN:
11640
American (AMR)
AF:
0.353
AC:
8676
AN:
24574
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
3762
AN:
13482
East Asian (EAS)
AF:
0.909
AC:
20217
AN:
22234
South Asian (SAS)
AF:
0.425
AC:
23128
AN:
54432
European-Finnish (FIN)
AF:
0.386
AC:
15082
AN:
39038
Middle Eastern (MID)
AF:
0.313
AC:
1030
AN:
3288
European-Non Finnish (NFE)
AF:
0.316
AC:
67745
AN:
214524
Other (OTH)
AF:
0.375
AC:
7961
AN:
21240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3977
7955
11932
15910
19887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.447
AC:
67762
AN:
151760
Hom.:
17371
Cov.:
30
AF XY:
0.450
AC XY:
33348
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.667
AC:
27552
AN:
41338
American (AMR)
AF:
0.355
AC:
5413
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1002
AN:
3462
East Asian (EAS)
AF:
0.892
AC:
4566
AN:
5120
South Asian (SAS)
AF:
0.430
AC:
2068
AN:
4810
European-Finnish (FIN)
AF:
0.399
AC:
4222
AN:
10574
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.320
AC:
21742
AN:
67896
Other (OTH)
AF:
0.402
AC:
845
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1681
3362
5042
6723
8404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.383
Hom.:
19721
Bravo
AF:
0.459
Asia WGS
AF:
0.643
AC:
2235
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.4
DANN
Benign
0.52
PhyloP100
-0.57
PromoterAI
0.025
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12976445; hg19: chr19-52196453; COSMIC: COSV59035606; API